L. Smaldone
发表
M. Rozencweig,
R. Canetta,
K. Bragman,
1988,
Cancer treatment reviews.
C. Viscoli,
R. Horwitz,
L. Smaldone,
1988,
Archives of internal medicine.
A. F. Stewart,
J. Waldron,
K. Insogna,
1985,
The Journal of clinical endocrinology and metabolism.
M. Beltangady,
S. Kelley,
M. Rozencweig,
1990,
Reviews of infectious diseases.
S. Kelley,
M. Rozencweig,
R. Canetta,
1990,
Seminars in oncology.
S. Kelley,
M. Rozencweig,
R. Canetta,
1989,
Cancer treatment reviews.
M. Rozencweig,
C. Franks,
R. Canetta,
1987,
Oncology.
N. Onetto,
S. Kelley,
C. Anderson,
1992,
Seminars in oncology.
J. Lazo,
K. A. Kennedy,
L. Smaldone,
1985,
Cancer research.
Rates and risk factors for adverse events associated with didanosine in the expanded access program.
I. Pike,
M. Daniels,
L. Smaldone,
1994,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
A. Cross,
D. Peterson,
I. Frank,
1994,
Annals of Internal Medicine.
K. K. Lai,
D. Katzenstein,
M. Hirsch,
1995
.
M. Beltangady,
M. Rozencweig,
R. Yarchoan,
1993,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
E. Vokes,
G. Fleming,
L. Janisch,
2004,
Cancer Chemotherapy and Pharmacology.
A. Cross,
R. E. Anderson,
L. Dunkle,
1995,
The Journal of infectious diseases.
M. Wainberg,
M. Schechter,
H. Salomón,
1995,
Annals of Internal Medicine.
T. Merigan,
J. Kahn,
S. Lagakos,
1992,
The New England journal of medicine.